Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis

International Journal of Clinical and Laboratory Research

Volumn 28, Issue 1, 1998, Pages 55-68

  Vacca, A ^a   Ribatti, D ^b   Iurlaro, M ^a   Albini, A ^c   Minischetti, M ^a   Bussolino, F ^d   Pellegrino, A ^a   Ria, R ^a   Rusnati, M ^e   Presta, M ^e   Vincenti, V ^f   Persico, M G ^f   Dammacco, F ^a  

^a POLICLINICO   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

Angiogenesis; Endothelial cell; Human lymphoblastoid cells; Matrix degrading enzymes

Indexed keywords

COLLAGEN; COLLAGENASE; ENDOTHELIAL CELL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GELATINASE; GELATINASE A; GELATINASE B; LAMININ; LYMPHOKINE; MATRIGEL; METALLOPROTEINASE; PROTEOGLYCAN; TUMOR PROTEIN; UROKINASE; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANCER INVASION; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; CELL MOTION; CHICK EMBRYO; CULTURE MEDIUM; CYTOLOGY; DRUG COMBINATION; ENZYMOLOGY; FEMALE; HUMAN; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MORPHOGENESIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; SECRETION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CHICK EMBRYO; COLLAGEN; COLLAGENASES; CULTURE MEDIA, CONDITIONED; DRUG COMBINATIONS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 2; GELATINASES; HUMANS; LAMININ; LYMPHOCYTES; LYMPHOKINES; LYMPHOPROLIFERATIVE DISORDERS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; MORPHOGENESIS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; MURINAE;

EID: 7144254439     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990050018     Document Type: Article

References (58)

1. Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Hematology (Williams), 5th edn. New York: McGraw-Hill, 1995.
2. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327.
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27.
4. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993; 73: 161.
5. Fessler L, Duncan K, Fessler JH, Salo T, Tryggvason K. Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem 1984; 259: 9783.
6. Murphy G, Ward R, Hembry RM, Reynolds JJ, Kühn K, Tryggvason K. Characterization of gelatinase from pig polymorphonuclear leukocytes. Biochem J 1989; 258: 463.
7. Werb Z, Banda MJ, Jones A. Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins and collagen by proteinases isolated from macrophages. J Exp Med 1980; 152: 1340.
8. Noël A, Emonard H, Polette M, Birembaut P, Foidart JM. Role of matrix, fibroblasts and type IV collagenases, in tumor progression and invasion. Pathol Res Pract 1994; 190: 934.
9. Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 1994; 7: 2062.
10. Testa JE, Quigley JP. The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Metastasis Rev 1990; 9: 353.
11. Folkman J. Tumor angiogenesis. In: Holland JF, Frei E III, Bast RC, Kufe DW Jr, Morton DL, Weichselbaum RR, eds. Cancer medicine, 3rd edn, vol I. Philadelphia: Lea and Febiger; 1993: 153-170.
12. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA. Molecular aspects of tumor cell invasion and metastasis. Cancer 1993; 71: 1368.
13. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995; 147: 9.
14. Mostafa LK, Jones DB, Wright DH. Mechanism of the induction of angiogenesis by human neoplastic lymphoid tissue: studies on the chorioallantoic membrane (CAM) of the chick embryo. J Pathol 1990; 132: 191.
15. Kobayashi M, Hamada J, Li YQ, Shinobu N, Imamura M, Okada F, Takeichi N, Hosokawa M. A possible role of 92 kDa type IV collagenase in the extramedullary tumor formation in leukemia. Jpn J Cancer Res 1995; 86: 298.
16. Bussolino F, Di Renzo MF, Ziehe M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629.
17. Edgell CJS, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 1983; 80: 3734.
18. Albini A, Repetto L, Carlone S, Benelli R, Soria M, Monaco L, Gendelman R, De Filippi P, Bussolino F, Parravicini C. Characterization of Kaposi's sarcoma-derived cell cultures from an epidemic and a classic case. Int J Oncol 1992; 1: 723.
19. De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Cornacchiulo V, Santini G, Crovatto M, Gloghini A, Dammacco F, Boiocchi M. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995; 88: 1687.
20. Huhtala P, Tuuttila A, Chow LT, Lohi J, Keski-Oja J, Tryggvason K. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92-and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem 1991; 266: 16485.
21. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEvan RN. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239.
22. Colombi M, Barllati S, Magdelenat H, Fisher-Szagarz B. Relationship between multiple forms of plasminogen activator in human breast tumors and plasma and presence of metastasis in lymph nodes. Cancer Res 1986; 44: 2971.
23. Presta M, Majer JAM, Ragnotti G. The mitogenic signaling pathway but not plasminogen activator-induced pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells. J Cell Biol 1989; 109: 1877.
24. Bussolino F, Arese M, Montrucchio G, Barra L, Primo L, Benelli R, Sanavio F, Aglietta M, Ghico D, Rola-Pleszczynski M, Bosia A, Albini A, Camussi G. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J Clin Invest 1995; 96: 940.
25. Kueng K, Silfer E, Eppenberger V. Quantification of cells cultured on 96-well plates. Anal Biochem 1989; 182: 16.
26. Albini A, Melchiori A, Parodi S, Kleinman H. Chemotaxis and invasiveness. In: Lapière CM, Krieg T, eds. Connective tissue disease of the skin. New York: Marcel Dekker; 1993: 129-145.
27. Passaniti ARM, Taylor R, Pili Y, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 1992; 67: 519.
28. Drabkin DL, Austin JH. Spectrophotometric constants for common hemoglobin derivatives in human, dog, and rabbit blood. J Biol Chem 1932; 98: 719.
29. Vacca A, Ribatti D, Roncali L, Lospalluti M, Serio G, Carrel S. Dammacco F. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 1993; 72: 455.
30. Ribatti D, Urbinati C, Nico B, Rusnati M, Roncali L, Presta M. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 1995; 170: 39.
31. Olivo M, Bhardway R, Schulze-Osthoff K, Sorg C, Jürgen-Jacob H, Flamme I. A comparative study on the effects of tumor necrosis factor-α (TNF-α), human angiogenic factor (h-AF) and basic fibroblast growth factor (bFGF) on the chorioallantoic membrane of the chick embryo. Anat Rec 1992; 234: 105.
32. Van Wart HE, Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase gene family. Proc Natl Acad Sci USA 1990; 85: 5578.
33. Dano K, Andreasen PA, Grondahl-Hansen J, Krinstensen JP, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985; 44: 139.
34. Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun MT. Lymphocyte synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells Proc Natl Acad Sci USA 1994; 91: 2890.
35. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsburn M. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 1995; 55: 4140.
36. Florkiewicz RZ, Sommer A. Human basic fibroblast growth factor gene encodes fourpolypeptides: three initiate translation from non-AUG codons. Proc Natl Acad Sci USA 1989; 86: 3978.
37. Pepper MS, Mandriota SJ, Vassalli JD, Orci L, Montesano R. Angiogenesis-regulating cytokines: activities and interactions. Curr Top Microbiol Immunol 1996; 213: 31.
38. Kossakowska AE, Huchcroft SA, Urbanski SJ, Edwards DR. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer 1996; 73: 1401.
39. Ries C, Kolb H, Petrides PE. Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-α as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood 1994; 83: 3638.
40. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T, Okada Y. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U-937 monoblastoid cells: correlation with cellular invasion. J Cell Sci 1993; 104: 991.
41. Dittmann KH, Lottspeich F, Ries C, Petrides PE. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs). Exp Hematol 1995; 23: 155.
42. Vassalli J-D, Pepper MS. Membrane proteases in focus. Nature 1994; 370: 14.
43. Philip-Joet F, Alessi MC, Philip-Joet C, Aillaud M, Barriere JR, Arnauid A, Juhan-Vague I. Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J 1995; 8: 1352.
44. Norrby K. Heparin and angiogenesis: a low molecular weight fraction inhibits and a high molecular weight fraction stimulates angiogenesis systemically. Haemostasis 1993; 23: 141.
45. Ferrara N. Vascular endothelial growth factor. Eur J Cancer 1996; 32A: 2413.
46. Rusnati M, Presta M. Interaction of angiogenic basic fibroblast growth factor with endothelial heparan sulfate proteoglycans. Biological implications in neovascularization. Int J Clin Lab Res 1996; 26: 15.
47. Brach MA, Hermann F. Interleukin 6: present and future. Int J Clin Lab Res 1992; 22: 143.
48. Adami F, Guarini A, Pini M, Siviero F, Sancetta R, Massaia M, Trentin L, Foà R, Semenzato G. Serum levels of tumor necrosis factor-α in patients with B-cell chronic lymphocytic leukaemia. Eur J Cancer 1994; 30A: 1259.
49. Nakamura M, Merchav S, Carter A, Ernst TJ, Demetri GD, Furukawa Y, Anderson K, Freedman AS, Griffin JD. Expression of a novel 3.5-kb macrophage colony-stimulating factor transcript in human myeloma cells. J Immunol 1989; 143: 3543.
50. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W. The vascular endothelial growth factor receptor Fit-1 mediates biological activities: implications for a functional role of placental growth factor in monocyte activation and chemotaxis. J Biol Chem 1996; 271: 17629.
51. Sozzani S, Locati M, Allavena P, Van Damme J, Mantovani A. Chemokines: a superfamily of chemotactic cytokines. Int J Clin Lab Res 1996; 25: 69.
52. Polverini PF. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases. Eur J Cancer 1996; 32A: 2430.
53. Kittas C, Hansmann ML, Borisch B, Feller AC, Lennert K. The blood microvasculature in T-cell lymphomas. A morphological, ultrastructural and immunohistochemical study. Virchows Arch [A] 1985; 405: 439.
54. Ribatti D, Vacca A, Nico B, Fanelli M, Roncali L. Dammacco F. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study. Eur J Haematol 1996; 56: 45
55. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Folkman J. Spectrum of tumor angiogenesis in bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815.
56. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87: 503.
57. Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 1996; 32A: 2534.
58. Talbot DC, Brown PD. Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer. Eur J Cancer 1996; 32A: 2528.